Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional Results available

A Study to Investigate Safety, Tolerability, and PK of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

ClinicalTrials.gov ID: NCT05437419

Public ClinicalTrials.gov record NCT05437419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1, Randomized, Placebo-controlled, Double-blind, Multiple Ascending Dose Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral Doses of TCK-276 in Patients With Rheumatoid Arthritis

Study identification

NCT ID
NCT05437419
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Teijin America, Inc.
Industry
Enrollment
32 participants

Conditions and interventions

Interventions

  • TCK-276 Drug
  • TCK-276 Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 64 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 9, 2022
Primary completion
Jul 19, 2023
Completion
Jul 26, 2023
Last update posted
Oct 14, 2024

2022 – 2023

United States locations

U.S. sites
8
U.S. states
3
U.S. cities
6
Facility City State ZIP Site status
Orange County Research Center Tustin California 92780
St. Jude Clinical Research, LLC Doral Florida 33172
SouthCoast Research Center, Inc Miami Florida 33136
Allied Biomedical Research Institute Miami Florida 33155
San Marcus Research Clinic, Inc. Miami Lakes Florida 33014
Floridian Clinical Research, LLC Miami Lakes Florida 33016
Clinical Site Partners, LLC dba CSP Orlando Winter Park Florida 32789
SMS Clinical Research, LLC Mesquite Texas 75149

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05437419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 14, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05437419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →